AngioDynamics
(NASDAQ) ANGO
AngioDynamics Financials at a Glance
Market Cap
$528.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$313.73M
Net Income (TTM)
-$31.39M
EPS (TTM)
-$0.76
P/E Ratio
-16.84
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$12.80
Volume
202,944.785
Open
$12.85
Price
$12.80
Volume
202,944.785
Open
$12.85
Previous Close
$12.79
Daily Range
$12.55 - $12.94
52-Week Range
$8.36 - $13.99
Estimated Earnings Date
Jul 14, 2026
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$12.80
Volume
202,944.785
Open
$12.85
Previous Close
$12.79
Daily Range
$12.55 - $12.94
52-Week Range
$8.36 - $13.99
Estimated Earnings Date
Jul 14, 2026
ANGO News
ANGO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AngioDynamics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
675
CEO
James Christopher Clemmer
Website
www.angiodynamics.comHeadquarters
Latham, NY 12110, US
ANGO Financials
Key Financial Metrics (TTM)
Gross Margin
53.45%
Operating Margin
-8.08%
Net Income Margin
-10.00%
Return on Equity
-17.65%
Return on Capital
-20.69%
Return on Assets
-12.04%
Earnings Yield
-5.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$528.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
41.32M
Volume
202.94K
Avg. Volume
353.75K
Financials (TTM)
Gross Profit
$167.69M
Operating Income
-$25.36M
EBITDA
-$5.44M
Operating Cash Flow
$4.45M
Capital Expenditure
-$2.95M
Free Cash Flow
$1.50M
Cash & ST Invst.
$37.81M
Total Debt
$11.39M
AngioDynamics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$78.42M
+8.9%
Gross Profit
$41.48M
+6.7%
Gross Margin
52.89%
N/A
Market Cap
$528.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$706.51K
N/A
Employees
748
N/A
Net Income
-$8.08M
-83.4%
EBITDA
-$2.39M
-627.4%
Quarterly Fundamentals
Total Cash
$37.81M
-15.5%
Total Debt
$11.39M
+127.9%
Accounts Receivable
$45.55M
-7.0%
Inventory
$58.58M
-7.2%
Long Term Debt
$9.68M
N/A
Short Term Debt
$1.71M
-65.7%
Return on Assets
-12.04%
N/A
Return on Invested Capital
-13.03%
N/A
Free Cash Flow
-$4.13M
+72.4%
Operating Cash Flow
-$3.11M
+76.4%